B
Overview
BioMed Realty is a real estate investment trust focusing on lab and office spaces for the life sciences. It builds, owns, and manages properties in US and UK innovation hubs and signs long-term leases with pharmaceutical, biotechnology, research institutions, and government tenants to generate rental income. It differentiates itself as one of the largest private owners and operators of dedicated life science real estate, using specialized facilities and active asset management to attract premier tenants. Its goal is to secure stable, long-term rental revenue while growing a top portfolio that supports biotech and pharmaceutical ecosystems.
Work here?Claim your company
Simplify's take
What believers are saying
- 2026 GRESB ranked BioMed first in Technology/Science, strengthening institutional credibility.
- November 2026 leases at Flatiron Park, Babraham, and Assembly Innovation Park show demand.
- University Park stayed 96% occupied after BioMed closed $1.32 billion refinancing in 2025.
What critics are saying
- Takeda seeks 630,000 square feet of Cambridge subleases, pressuring Kendall Square rents.
- BioMed sued a flexible lab operator for unpaid rent in September 2025, signaling tenant stress.
- A prolonged Cambridge vacancy cycle could break refinancing assumptions and force asset sales.
What makes BioMed Realty unique
- Blackstone-backed, largest private operator of life science and advanced technology real estate.
- Owns 17-million-square-foot portfolio in premier clusters like Kendall Square, Boulder, and Cambridge.
- Builds tenant-retention amenities, including The Platform, combining labs with community infrastructure.
Help us improve and share your feedback! Did you find this helpful?